கிரெக் சோவ் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from கிரெக் சோவ். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In கிரெக் சோவ் Today - Breaking & Trending Today

Aptose Expands Senior Leadership Team


Aptose Expands Senior Leadership Team
Aptose Biosciences Inc. a clinical stage company developing highly differentiated therapeutics that target the underlying mechanisms of cancer, today announced the appointment of two key members to its management team to support the company’s expanding clinical CMC and regulatory functions: George P. Melko, Pharm.D., joins Aptose as Vice President, Regulatory Affairs; and Robert B. Killion Jr., Ph.D. has been …
George Melko, Pharm.D. joins as Vice President, Regulatory Affairs
Robert Killion, Ph.D. appointed Vice President, CMC
Aptose Biosciences Inc. (Nasdaq: APTO; TSX: APS), a clinical stage company developing highly differentiated therapeutics that target the underlying mechanisms of cancer, today announced the appointment of two key members to its management team to support the company’s expanding clinical CMC and regulatory functions: George P. Melko, Pharm.D., joins Aptose as Vice President, Regulatory Affairs ....

United States , Georgep Melko , Aptose Biosciences , Robertb Killion Jr , Poulenc Rorer , Robert Killion , Susan Pietropaolo , Greg Chow , George Melko , Lifesci Advisors , Regulatory Affairs , Astrazeneca Pharmaceuticals , Aptose Biosciences Inc , European Medicines Agency , Incyte Corporation , Vice President , Tmunity Therapeutics , Tessa Therapeutics , Investigational New Drug , Senior Director , Chief Executive , Sci Advisors , Managing Director , ஒன்றுபட்டது மாநிலங்களில் , ராபர்ட் கிலியந் , கிரெக் சோவ் ,

Aptose to Release Fourth Quarter and Year End December 31, 2020 Financial Results and Hold Conference Call on March 23, 2021


Aptose to Release Fourth Quarter and Year End December 31, 2020 Financial Results and Hold Conference Call on March 23, 2021
Aptose Biosciences Inc. a clinical stage company developing highly differentiated therapeutics that target the underlying mechanisms of cancer, will release its financial results for the year and quarter ended December 31, 2020, on Tuesday, March 23, 2021 after the close of the market. The live conference call can also be accessed through a link on the Investor Relations section of Aptose’s website at An archived …
Aptose Biosciences Inc. (Nasdaq: APTO; TSX: APS), a clinical stage company developing highly differentiated therapeutics that target the underlying mechanisms of cancer, will release its financial results for the year and quarter ended December 31, 2020, on Tuesday, March 23, 2021 after the close of the market. ....

Aptose Biosciences , Susan Pietropaolo , Greg Chow , Lifesci Advisors , Aptose Biosciences Inc , Investor Relations , Sci Advisors , Managing Director , Vice President , கிரெக் சோவ் , முதலீட்டாளர் உறவுகள் , நிர்வகித்தல் இயக்குனர் , துணை ப்ரெஸிடெஂட் ,